Backs FY25 revenue view $900M-$910M, consensus $904.45M. The company said, “The Company is reaffirming its previously issued guidance for full-year 2025 with revenue guidance of $900 to $910 million, gross margin guidance of 84% to 86% and diluted net income per share guidance of $0.40 to $0.50.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire Medical price target lowered to $97 from $116 at Leerink
- Inspire Medical Systems Announces $200M Share Buyback
- Inspire Medical board authorizes up to $200M share repurchase program
- Inspire Medical Systems Stock (INSP) Dives After Reporting a Q2 Beat & Guidance Cut
- Inspire Medical’s Mixed Earnings Call: Growth Amid Challenges